Oncology CRO / Cancer CRO (Contract / Clinical Research Organization)

Cancer treatment has traditionally consisted of surgery, chemotherapy, and radiotherapy, but new therapies have recently emerged as promising options to combat this disease. Antibody drug conjugates (ADCs) use high specificity to bring a tumor-killing agent to its location to eliminate tumor cells only, leaving healthy tissue untouched. Additionally, immuno-oncological approaches are being developed which leverage patients’ own immune systems to eliminate cancer cells, and scientists and doctors are seeing real promise in such targeted therapies.

These molecular and possibly personalized approaches take scientific expertise – and a deep understanding of methods such as mAbs, adoptive cell therapy, immune checkpoint therapy and more – in order to fully realize the potential of such complex biotherapeutics.